Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Feb 15;99(4):559–564. doi: 10.1172/JCI119195

von Willebrand factor.

Z M Ruggeri 1
PMCID: PMC507834  PMID: 9045854

Full Text

The Full Text of this article is available as a PDF (257.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back L. D., Radbill J. R., Crawford D. W. Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man. J Biomech. 1977;10(5-6):339–353. doi: 10.1016/0021-9290(77)90006-9. [DOI] [PubMed] [Google Scholar]
  2. Bahnak B. R., Wu Q. Y., Coulombel L., Assouline Z., Kerbiriou-Nabias D., Piétu G., Drouet L., Caen J. P., Meyer D. Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol. 1989 Feb;138(2):305–310. doi: 10.1002/jcp.1041380212. [DOI] [PubMed] [Google Scholar]
  3. Bellinger D. A., Nichols T. C., Read M. S., Reddick R. L., Lamb M. A., Brinkhous K. M., Evatt B. L., Griggs T. R. Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8100–8104. doi: 10.1073/pnas.84.22.8100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Budde U., Scharf R. E., Franke P., Hartmann-Budde K., Dent J., Ruggeri Z. M. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood. 1993 Sep 15;82(6):1749–1757. [PubMed] [Google Scholar]
  5. Christophe O., Obert B., Meyer D., Girma J. P. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673. Blood. 1991 Nov 1;78(9):2310–2317. [PubMed] [Google Scholar]
  6. Cruz M. A., Yuan H., Lee J. R., Wise R. J., Handin R. I. Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem. 1995 May 5;270(18):10822–10827. doi: 10.1074/jbc.270.18.10822. [DOI] [PubMed] [Google Scholar]
  7. Denis C., Baruch D., Kielty C. M., Ajzenberg N., Christophe O., Meyer D. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. Arterioscler Thromb. 1993 Mar;13(3):398–406. doi: 10.1161/01.atv.13.3.398. [DOI] [PubMed] [Google Scholar]
  8. Dent J. A., Berkowitz S. D., Ware J., Kasper C. K., Ruggeri Z. M. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6306–6310. doi: 10.1073/pnas.87.16.6306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dent J. A., Galbusera M., Ruggeri Z. M. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest. 1991 Sep;88(3):774–782. doi: 10.1172/JCI115376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fujimura Y., Titani K., Holland L. Z., Roberts J. R., Kostel P., Ruggeri Z. M., Zimmerman T. S. A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem. 1987 Feb 5;262(4):1734–1739. [PubMed] [Google Scholar]
  11. Fujimura Y., Titani K., Holland L. Z., Russell S. R., Roberts J. R., Elder J. H., Ruggeri Z. M., Zimmerman T. S. von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem. 1986 Jan 5;261(1):381–385. [PubMed] [Google Scholar]
  12. Furlan M., Robles R., Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996 May 15;87(10):4223–4234. [PubMed] [Google Scholar]
  13. Fuster V., Badimon L., Badimon J. J., Chesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992 Jan 23;326(4):242–250. doi: 10.1056/NEJM199201233260406. [DOI] [PubMed] [Google Scholar]
  14. Fuster V., Badimon L., Badimon J. J., Chesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992 Jan 30;326(5):310–318. doi: 10.1056/NEJM199201303260506. [DOI] [PubMed] [Google Scholar]
  15. Fuster W., Bowie E. J., Lewis J. C., Fass D. N., Owen C. A., Jr, Brown A. L. Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. J Clin Invest. 1978 Mar;61(3):722–730. doi: 10.1172/JCI108985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Goto S., Salomon D. R., Ikeda Y., Ruggeri Z. M. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem. 1995 Oct 6;270(40):23352–23361. doi: 10.1074/jbc.270.40.23352. [DOI] [PubMed] [Google Scholar]
  17. Ikeda Y., Handa M., Kawano K., Kamata T., Murata M., Araki Y., Anbo H., Kawai Y., Watanabe K., Itagaki I. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991 Apr;87(4):1234–1240. doi: 10.1172/JCI115124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jansson J. H., Nilsson T. K., Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991 Nov;66(5):351–355. doi: 10.1136/hrt.66.5.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kroll M. H., Hellums J. D., McIntire L. V., Schafer A. I., Moake J. L. Platelets and shear stress. Blood. 1996 Sep 1;88(5):1525–1541. [PubMed] [Google Scholar]
  20. Moake J. L., Byrnes J. J., Troll J. H., Rudy C. K., Weinstein M. J., Colannino N. M., Hong S. L. Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome. Blood. 1984 Sep;64(3):592–598. [PubMed] [Google Scholar]
  21. Moake J. L., Rudy C. K., Troll J. H., Weinstein M. J., Colannino N. M., Azocar J., Seder R. H., Hong S. L., Deykin D. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982 Dec 2;307(23):1432–1435. doi: 10.1056/NEJM198212023072306. [DOI] [PubMed] [Google Scholar]
  22. Moroi M., Jung S. M., Okuma M., Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989 Nov;84(5):1440–1445. doi: 10.1172/JCI114318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nichols T. C., Bellinger D. A., Johnson T. A., Lamb M. A., Griggs T. R. von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ Res. 1986 Jul;59(1):15–26. doi: 10.1161/01.res.59.1.15. [DOI] [PubMed] [Google Scholar]
  24. Nichols T. C., Samama C. M., Bellinger D. A., Roussi J., Reddick R. L., Bonneau M., Read M. S., Bailliart O., Koch G. G., Vaiman M. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2455–2459. doi: 10.1073/pnas.92.7.2455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nieuwenhuis H. K., Akkerman J. W., Houdijk W. P., Sixma J. J. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature. 1985 Dec 5;318(6045):470–472. doi: 10.1038/318470a0. [DOI] [PubMed] [Google Scholar]
  26. Peterson D. M., Stathopoulos N. A., Giorgio T. D., Hellums J. D., Moake J. L. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987 Feb;69(2):625–628. [PubMed] [Google Scholar]
  27. Read M. S., Smith S. V., Lamb M. A., Brinkhous K. M. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood. 1989 Aug 15;74(3):1031–1035. [PubMed] [Google Scholar]
  28. Ruggeri Z. M., Ware J. von Willebrand factor. FASEB J. 1993 Feb 1;7(2):308–316. doi: 10.1096/fasebj.7.2.8440408. [DOI] [PubMed] [Google Scholar]
  29. Savage B., Saldívar E., Ruggeri Z. M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996 Jan 26;84(2):289–297. doi: 10.1016/s0092-8674(00)80983-6. [DOI] [PubMed] [Google Scholar]
  30. Savage B., Shattil S. J., Ruggeri Z. M. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem. 1992 Jun 5;267(16):11300–11306. [PubMed] [Google Scholar]
  31. Scott J. P., Montgomery R. R., Retzinger G. S. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J Biol Chem. 1991 May 5;266(13):8149–8155. [PubMed] [Google Scholar]
  32. Siedlecki C. A., Lestini B. J., Kottke-Marchant K. K., Eppell S. J., Wilson D. L., Marchant R. E. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996 Oct 15;88(8):2939–2950. [PubMed] [Google Scholar]
  33. Tangelder G. J., Slaaf D. W., Arts T., Reneman R. S. Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles. Am J Physiol. 1988 Jun;254(6 Pt 2):H1059–H1064. doi: 10.1152/ajpheart.1988.254.6.H1059. [DOI] [PubMed] [Google Scholar]
  34. Weiss H. J., Hawiger J., Ruggeri Z. M., Turitto V. T., Thiagarajan P., Hoffmann T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest. 1989 Jan;83(1):288–297. doi: 10.1172/JCI113871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yao S. K., Ober J. C., Garfinkel L. I., Hagay Y., Ezov N., Ferguson J. J., Anderson H. V., Panet A., Gorecki M., Buja L. M. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation. 1994 Jun;89(6):2822–2828. doi: 10.1161/01.cir.89.6.2822. [DOI] [PubMed] [Google Scholar]
  36. Zahger D., Fishbein M. C., Garfinkel L. I., Shah P. K., Forrester J. S., Regnstrom J., Yano J., Cercek B. VCL, an antagonist of the platelet GP1b receptor, markedly inhibits platelet adhesion and intimal thickening after balloon injury in the rat. Circulation. 1995 Sep 1;92(5):1269–1273. doi: 10.1161/01.cir.92.5.1269. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES